価格表

在庫・価格 : 2025年10月08日 10時31分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Rat VEGF MAb (Clone 123704)
データシート※最新のデータシートでない場合があります
MAB564-500 RSDアールアンドディー システムズ
R&D Systems, Inc.
500 μg ¥266,000
(未発注)
追加

在庫・価格 : 2025年10月08日 10時31分 現在

Anti-Rat VEGF MAb (Clone 123704)

  • 商品コード:MAB564-500
  • メーカー:RSD
  • 包装:500μg
  • 価格: ¥266,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Escribano M et al. Aspirin inhibits endothelial nitric oxide synthase (eNOS) and Flk-1 (vascular endothelial growth factor receptor-2) prior to rat colon tumour development. Clin. Sci. 2004 Jan;106(1):83-91
Escribano M et al
2004/01/01
Species: Rat, Applications: Western Blot PubMed
2 Peng Y et al. Platelet rich plasma clot releasate preconditioning induced PI3K/AKT/NFκB signaling enhances survival and regenerative function of rat bone marrow mesenchymal stem cells in hostile microenvironments. Stem Cells Dev. 2013 Dec;22(24):323
Peng Y et al
2013/01/01
Species: Rat, Applications: ICC PubMed
3 Kern TS et al. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 2007 Feb;56(2):373-9
Kern TS et al
2007/01/01
Species: Rat, Applications: Western Blot PubMed
4 Gao X et al. Protective effects of mesenchymal stem cells overexpressing extracellular regulating kinase 1/2 against stroke in rats. Brain Res. Bull. 2019 Jul;149:42-52
Gao X et al
2019/01/01
Species: Rat, Applications: Western Blot PubMed
  • No.: 1
  • 文献情報:
    Escribano M et al. Aspirin inhibits endothelial nitric oxide synthase (eNOS) and Flk-1 (vascular endothelial growth factor receptor-2) prior to rat colon tumour development. Clin. Sci. 2004 Jan;106(1):83-91
    Escribano M et al
    2004/01/01
  • 備考:
    Species: Rat, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Peng Y et al. Platelet rich plasma clot releasate preconditioning induced PI3K/AKT/NFκB signaling enhances survival and regenerative function of rat bone marrow mesenchymal stem cells in hostile microenvironments. Stem Cells Dev. 2013 Dec;22(24):323
    Peng Y et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: ICC
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Kern TS et al. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 2007 Feb;56(2):373-9
    Kern TS et al
    2007/01/01
  • 備考:
    Species: Rat, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gao X et al. Protective effects of mesenchymal stem cells overexpressing extracellular regulating kinase 1/2 against stroke in rats. Brain Res. Bull. 2019 Jul;149:42-52
    Gao X et al
    2019/01/01
  • 備考:
    Species: Rat, Applications: Western Blot
  • 参照:
    PubMed